ES8306360A1 - Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico. - Google Patents
Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico.Info
- Publication number
- ES8306360A1 ES8306360A1 ES504388A ES504388A ES8306360A1 ES 8306360 A1 ES8306360 A1 ES 8306360A1 ES 504388 A ES504388 A ES 504388A ES 504388 A ES504388 A ES 504388A ES 8306360 A1 ES8306360 A1 ES 8306360A1
- Authority
- ES
- Spain
- Prior art keywords
- magnesium
- calcium
- hydroxy
- manufacture
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical class OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229940006015 4-hydroxybutyric acid Drugs 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 239000000920 calcium hydroxide Substances 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000292 calcium oxide Substances 0.000 abstract 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- AZRRVLSHRWGNRS-UHFFFAOYSA-L calcium;4-hydroxybutanoate Chemical compound [Ca+2].OCCCC([O-])=O.OCCCC([O-])=O AZRRVLSHRWGNRS-UHFFFAOYSA-L 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 abstract 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 abstract 1
- 239000000347 magnesium hydroxide Substances 0.000 abstract 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 abstract 1
- 239000000395 magnesium oxide Substances 0.000 abstract 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract 1
- QWZIZKOBUUSCLO-UHFFFAOYSA-L magnesium;4-hydroxybutanoate Chemical compound [Mg+2].OCCCC([O-])=O.OCCCC([O-])=O QWZIZKOBUUSCLO-UHFFFAOYSA-L 0.000 abstract 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229940125724 sleeping drug Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE SALES NO HIGROSCOPICAS DEL ACIDO 4-HIDROXIBUTIRICO. CONSISTE EN DISOCIAR HIDROLITICAMENTE GAMMA-BUTIROLACTONA POR REACCION CON UN HIDROXIDO, OXIDO O CARBONATO DE CALCIO O DE MAGNESIO; LA REACCION TIENE LUGAR A TEMPERATURAS INFERIORES A 80 C. A CONTINUACION TIENE LUGAR LA RECRISTALIZACION DE LA MASA CRISTALINA. CUANDO LA REACCION SE EFECTUA CON HIDROXIDO, OXIDO O CARBONATO DE MAGNESIO, LA TEMPERATURA DE REACCION ES LA DE EBULLICION DE AGUA. SE OBTIENEN COMPUESTOS (I) EN QUE E ES CALCIO O MAGNESIO Y X ES 0, 4, 5 O 6 DE MODO QUE CUANDO E ES CALCIO, X ES 0.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3027390 | 1980-07-17 | ||
| DE19803049869 DE3049869A1 (de) | 1980-11-20 | 1980-11-20 | Erdalkalisalze der 4-hydroxybuttersaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES504388A0 ES504388A0 (es) | 1983-06-01 |
| ES8306360A1 true ES8306360A1 (es) | 1983-06-01 |
Family
ID=25786727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES504388A Expired ES8306360A1 (es) | 1980-07-17 | 1981-07-16 | Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4393236A (es) |
| EP (1) | EP0044801B1 (es) |
| AU (1) | AU7303981A (es) |
| DK (1) | DK283081A (es) |
| ES (1) | ES8306360A1 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058023A1 (es) * | 1992-10-29 | 1994-10-16 | Koehler Chemie Dr Franz | Derivados del acido 4-hidroxi-butirico. |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1217783B (it) * | 1988-06-03 | 1990-03-30 | Farmaceutico Ct S R L Lab | Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative |
| GB2299992A (en) * | 1995-04-20 | 1996-10-23 | Willem Jacob Serfontein | Complexes of magnesium and calcium |
| US6472431B2 (en) | 1998-12-23 | 2002-10-29 | Orphan Medical, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| EP1316309A1 (en) * | 1998-12-23 | 2003-06-04 | Orphan Medical Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| CA2486557A1 (en) * | 2002-06-13 | 2003-12-24 | Novartis Ag | Calcium salts of indole derived statins |
| IL150907A (en) * | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
| US8778398B2 (en) | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| US8771735B2 (en) * | 2008-11-04 | 2014-07-08 | Jazz Pharmaceuticals, Inc. | Immediate release dosage forms of sodium oxybate |
| US8410304B2 (en) * | 2009-04-15 | 2013-04-02 | Norac Pharma | Process for preparing gamma-hydroxybutyrate |
| EP2421808B1 (en) | 2009-04-23 | 2013-07-31 | Concert Pharmaceuticals Inc. | 4-hydroxybutyric acid analogs |
| MX391660B (es) | 2010-03-24 | 2025-03-21 | Jazz Pharmaceuticals Inc | Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas |
| JP2014513046A (ja) | 2011-02-14 | 2014-05-29 | コンサート ファーマシューティカルズ インコーポレイテッド | ４−ヒドロキシ酪酸の重水素化類似体 |
| US8591922B1 (en) | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
| US9050302B2 (en) | 2013-03-01 | 2015-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12186296B1 (en) | 2016-07-22 | 2025-01-07 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12478604B1 (en) | 2016-07-22 | 2025-11-25 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
| WO2019126215A1 (en) | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
| WO2019126214A1 (en) | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release |
| EP3740189A1 (en) | 2017-12-18 | 2020-11-25 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release |
| WO2019126216A1 (en) | 2017-12-18 | 2019-06-27 | Tris Phama, Inc. | Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
| WO2020106735A1 (en) | 2018-11-19 | 2020-05-28 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
| CN109369372A (zh) * | 2018-11-28 | 2019-02-22 | 上海欣海国际贸易有限公司 | 一种制备3-羟基丁酸盐的方法 |
| JP7553453B2 (ja) | 2019-03-01 | 2024-09-18 | フラメル アイルランド リミテッド | 食事摂取状態における改善された薬物動態を有するガンマ－ヒドロキシ酪酸塩組成物 |
| TW202139986A (zh) | 2020-02-21 | 2021-11-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 治療原發性嗜睡症之方法 |
| WO2022076824A1 (en) | 2020-10-08 | 2022-04-14 | Jazz Pharmaceuticals Ireland Limited | Sodium oxybate to treat idiopathic hypersomnia |
| CN112778123A (zh) * | 2021-01-19 | 2021-05-11 | 宁波酶赛生物工程有限公司 | 一种3-羟基丁酸钠晶型及其制备方法和应用 |
| AU2022246286A1 (en) * | 2021-03-20 | 2023-09-07 | Alkem Laboratories Limited | A process for the preparation of mixed oxybate salts and polymorphs thereof |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| CN121038779A (zh) | 2023-02-03 | 2025-11-28 | 特瑞斯制药公司 | 每晚一次的低钠羟丁酸盐组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA465270A (en) * | 1950-05-23 | Moore Kirk Philip | Process for the preparation of pure calcium alpha hydroxyisobutyrate and pure alpha hydroxyisobutyric acid | |
| GB922029A (en) * | 1960-05-19 | 1963-03-27 | Equilibre Biolog L | Therapeutic composition |
-
1981
- 1981-06-19 EP EP81730055A patent/EP0044801B1/de not_active Expired
- 1981-06-26 DK DK283081A patent/DK283081A/da not_active Application Discontinuation
- 1981-07-13 US US06/282,419 patent/US4393236A/en not_active Expired - Fee Related
- 1981-07-16 ES ES504388A patent/ES8306360A1/es not_active Expired
- 1981-07-16 AU AU73039/81A patent/AU7303981A/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058023A1 (es) * | 1992-10-29 | 1994-10-16 | Koehler Chemie Dr Franz | Derivados del acido 4-hidroxi-butirico. |
Also Published As
| Publication number | Publication date |
|---|---|
| ES504388A0 (es) | 1983-06-01 |
| US4393236A (en) | 1983-07-12 |
| AU7303981A (en) | 1982-01-21 |
| EP0044801A1 (de) | 1982-01-27 |
| EP0044801B1 (de) | 1984-02-15 |
| DK283081A (da) | 1982-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8306360A1 (es) | Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico. | |
| KR890700590A (ko) | 폴린산의 분리방법 | |
| GB1292768A (en) | Substituted benzylimidazolidinones and a process for the manufacture thereof | |
| CA2059103A1 (en) | Process for the preparation of (6s)- and (6r)-tetrahydrofolates | |
| MY101750A (en) | Improvements in or relating to calcium salts. | |
| MX166069B (es) | Procedimiento para producir proinsulina humana cristalina | |
| YU44187A (en) | Process for obtaining dermathan sulfate of pharmaceutic purity | |
| IL73746A (en) | Crystalline vancomycin diphosphate,its preparation,pharmaceutical compositions containing it and its conversion to vancomycin hydrochloride | |
| ES480721A1 (es) | Un procedimiento para aislar pseudomonato de litio. | |
| EP0207436A3 (en) | New cytidine-diphosphocholine salts, particularly suitable for oral use | |
| AU2908189A (en) | Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases | |
| ES8101610A1 (es) | Un procedimiento para la preparacion de acido 7-metoxi-5-oxo-5h-tiazolo (2,3-b)quinazolin-2-carboxilico | |
| HUT46292A (en) | Process for production of new salts of aryl-oxi-propanol-amines formed by diphenyl acetic acid | |
| SE8304704L (sv) | Forfarande for ombildning av gips | |
| GR3001567T3 (en) | Process for the preparation of beta-hydroxybutyric acid and its salts by means of hydrolysis of oligomers of beta-hydroxybutyric acid in a basic medium | |
| ES516748A0 (es) | "un procedimiento mejorado para producir en continuo persulfato de sodio". | |
| HUT34345A (en) | Process for producing tablets with controlled dissolution of active ingredients independent of ph | |
| GB1384194A (en) | Process for the production of trisodium or tripotassium citrate | |
| DE3068259D1 (en) | Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production | |
| IT1219459B (it) | Procedimento per produrre forme cristalline di sali di litio, potassio e magnesio di citidindifosfocolina, forme cristalline cosi' ottenute e loro impiego farmaceutico | |
| DE3564117D1 (en) | Double salt of desoxyfructosyl-serotonine and of creatinine, its preparation and medicaments containing it | |
| DE3067054D1 (en) | Process for producing solutions of aziridine-2-carboxylic acid salts | |
| FR2352819A1 (fr) | Procede de preparation de sels alcalins de l'ampicilline, notamment du sel de sodium | |
| PT81014A (en) | Process for preparing the crystalline sodium salt of d-6-<alpha-<(2-oxo-3-furfurylideneamine-imidazolidin-1-yl)-carbonylamino>-2-thienyl-acetamido> -penicillanic acid useful as medicament | |
| GB1172470A (en) | A Novel Imidazole Compound and a Process for Producing the same |